Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Verweij P, Danaietash P, Flamion B, Menard J, et al. Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension. Hypertension 2020 Feb 17:HYPERTENSIONAHA11914504.
PMID: 32063059


Privacy Policy